We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+7.48%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$111B
AUM Growth
+$4.45B
(+4.2%)
Cap. Flow
-$1.78B
Cap. Flow
% of AUM
-1.61%
Top 10 Holdings %
Top 10 Hldgs %
29%
Holding
4,480
New
63
Increased
1,265
Reduced
2,421
Closed
236
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$46M |
| 2 |
Palantir
PLTR
|
+$40.3M |
| 3 |
SW
Smurfit Westrock
SW
|
+$39.2M |
| 4 |
Dell
DELL
|
+$29.2M |
| 5 |
Avantor
AVTR
|
+$27.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$97.8M |
| 2 |
Eli Lilly
LLY
|
+$58.2M |
| 3 |
NVIDIA
NVDA
|
+$48.6M |
| 4 |
ExxonMobil
XOM
|
+$31.3M |
| 5 |
Bank of America
BAC
|
+$30.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.19% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 11.38% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Industrials | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Gyre Therapeutics
GYRE
$744M
| $131K | ﹤0.01% |
10,424
+133
| +1% | +$1.72K |
|
3152
BCE
BCE
$21.2B
| $131K | ﹤0.01% |
3,756
| – | – |
|
3153
AlTi Global
ALTI
$493M
| $129K | ﹤0.01% |
34,617
-2,826
| -8% | -$12.2K |
|
|
SBT
3154
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $129K | ﹤0.01% |
28,354
-1,838
| -6% | -$10K |
|
3155
Valhi
VHI
$450M
| $129K | ﹤0.01% |
3,856
+105
| +3% | +$2.45K |
|
3156
Full Truck Alliance
YMM
$9.99B
| $129K | ﹤0.01% |
14,269
| – | – |
|
3157
Rogers Communications
RCI
$18.6B
| $127K | ﹤0.01% |
3,169
| – | – |
|
3158
Quantum-Si Incorporated
QSI
$177M
| $127K | ﹤0.01% |
143,648
-1,551
| -1% | -$1.51K |
|
|
BRFS
3159
DELISTED
BRF SA
BRFS
| $126K | ﹤0.01% |
28,841
-1,460
| -5% | -$6.18K |
|
3160
Aemetis
AMTX
$124M
| $125K | ﹤0.01% |
54,238
+1,929
| +4% | +$5.41K |
|
3161
Acrivon Therapeutics
ACRV
$74M
| $124K | ﹤0.01% |
17,760
+1,551
| +10% | +$12.2K |
|
3162
PrimeEnergy Resources
PNRG
$298M
| $122K | ﹤0.01% |
883
+101
| +13% | +$12.5K |
|
3163
Lifecore Biomedical
LFCR
$190M
| $122K | ﹤0.01% |
24,667
-2,232
| -8% | -$11.7K |
|
3164
Sun Life Financial
SLF
$45.4B
| $121K | ﹤0.01% |
2,089
+40
| +2% | +$2.09K |
|
3165
908 Devices
MASS
$364M
| $121K | ﹤0.01% |
34,744
-2,952
| -8% | -$13.1K |
|
3166
Quest Resource Holding
QRHC
$31.6M
| $120K | ﹤0.01% |
15,029
-1,412
| -9% | -$12.1K |
|
|
QIPT
3167
DELISTED
Quipt Home Medical
QIPT
| $120K | ﹤0.01% |
40,975
-8,301
| -17% | -$25.6K |
|
3168
X4 Pharmaceuticals
XFOR
$460M
| $119K | ﹤0.01% |
5,949
-293
| -5% | -$6.11K |
|
3169
Puma Biotechnology
PBYI
$454M
| $119K | ﹤0.01% |
46,628
-3,642
| -7% | -$11K |
|
3170
Cadiz
CDZI
$291M
| $118K | ﹤0.01% |
38,907
-8,071
| -17% | -$26.3K |
|
3171
Lifeway Foods
LWAY
$481M
| $118K | ﹤0.01% |
4,547
-321
| -7% | -$5.37K |
|
|
QVCGA
3172
DELISTED
QVC Group Inc Series A
QVCGA
| $118K | ﹤0.01% |
3,861
-255
| -6% | -$8.09K |
|
|
RGLS
3173
DELISTED
Regulus Therapeutics
RGLS
| $117K | ﹤0.01% |
74,495
-1,977
| -3% | -$3.27K |
|
3174
ICL Group
ICL
$6.85B
| $117K | ﹤0.01% |
27,475
| – | – |
|
|
ASAI
3175
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
| $116K | ﹤0.01% |
16,918
-32
| -0.2% | -$283 |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2024 Portfolio in Review
As of Q3 2024, RhumbLine Advisers held 4,480 positions worth $111B, up 4.2% from $106B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
RhumbLine Advisers's Q3 2024 filing shows 63 new, 1,265 increased, 2,421 reduced and 236 closed positions. Its largest new stake was Smurfit Westrock: 860,959 shares worth $42.5M. The largest sale was Microsoft, an estimated $97.8M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2024 buy was Smurfit Westrock: 860,959 shares worth $42.5M.
- RhumbLine Advisers added most to Apple in Q3 2024, an estimated $46M increase.
- RhumbLine Advisers's biggest Q3 2024 reduction was Microsoft, cutting an estimated $97.8M.
- RhumbLine Advisers fully exited Expand Energy Corp in Q3 2024, selling an estimated $27.4M.
- RhumbLine Advisers's ten largest holdings make up 29% of its $111B portfolio in Q3 2024.
- RhumbLine Advisers opened 63 new positions and closed 236 in Q3 2024.
- RhumbLine Advisers's portfolio value rose 4.2% quarter-over-quarter to $111B.
Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.